37 results
8-K
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
On March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael W. (“Mike … .
In addition, on March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ravi M. Rao
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
, Chief Executive Officer of Autolus. “We’re very pleased to welcome Mike Bonney as our new Chairman. Mike brings a wealth of commercial and corporate … governance experience to the Board and Ravi Rao, M.D., adds clinical development and medical affairs experience in autoimmune and inflammatory disease
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, regulators, self-regulatory organizations and other stakeholders have expressed an interest in Environmental, Social and Corporate Governance (“ESG”) matters … disclosure and financial controls and corporate governance practices. Our senior management and other personnel will need to devote a substantial
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
to loans and Sections 302 and 906 related to certifications and (ii) the corporate governance requirements under regulations of The Nasdaq Stock Market LLC
8-K
EX-10.3
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, committee charters, corporate governance, ethics, conflict of interest, confidentiality, share ownership and trading policies and guidelines and other
8-K
go086t3elj6
10 Jan 24
Departure of Directors or Certain Officers
3:12pm
8-K
EX-99.1
xrr36
22 Dec 23
Departure of Directors or Certain Officers
8:24am
8-K
devzwny8ngtpptr
22 Dec 23
Departure of Directors or Certain Officers
8:24am
6-K
4lxyy85c6lvtnm rbr
20 Jun 23
Current report (foreign)
4:59pm
6-K
EX-1.1
1ayv45j
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
424B5
0wa9t c3t0k
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
pr31sx
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
v1otdmmcad ebgb9rl
1 Jul 22
Current report (foreign)
5:15pm
424B3
u5w3ryqff81pky
18 May 22
Prospectus supplement
4:09pm
F-3
5ka6gs
3 May 22
Shelf registration (foreign)
7:25pm
424B3
9tgxnnwm
3 May 22
Prospectus supplement
4:55pm
F-3
gnowpkqcqw7
14 Apr 22
Shelf registration (foreign)
9:30pm
6-K
n8l e7u0v
15 Sep 21
Autolus Therapeutics announces the appointment of John H. Johnson as non-executive chairman of its Board of Directors
4:30pm
6-K
EX-1
xrxti8zv3h
30 Jun 21
Annual Report and Accounts
6:05am